Schrödinger Announces Preclinical Data for CDC7 Program to Be Presented at AACR Virtual Annual Meeting 2021Business Wire • 03/10/21
Schrödinger, Inc. (SDGR) CEO Ramy Farid on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/04/21
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2020 and Provides Outlook for 2021Business Wire • 03/04/21
Schrödinger to Present at the H.C. Wainwright Global Life Sciences ConferenceBusiness Wire • 03/01/21
Schrödinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science InitiativesBusiness Wire • 02/25/21
Schrödinger Presents Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual MeetingBusiness Wire • 12/07/20
Schrödinger in drug development agreement with Bristol Myers worth up to $2.7 billion in milestone and royalty paymentsMarket Watch • 11/23/20
Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers SquibbBusiness Wire • 11/23/20
Schrödinger, Inc. (SDGR) CEO Ramy Farid on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/12/20
Schrödinger, Inc. Reports Third Quarter 2020 Financial Results and Business UpdateBusiness Wire • 11/12/20
Schrödinger to Present Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual MeetingBusiness Wire • 11/05/20
Schrödinger to Host Third Quarter 2020 Financial Results Conference Call and WebcastBusiness Wire • 11/05/20
Schrödinger, Inc.: Royalty Growth Is The Key Overlooked Factor For Long-Term ValueSeeking Alpha • 09/17/20